Revlimid

Still Revving Up With Revlimid
Motley Fool
Sat, 02/9/13 - 10:49 am
Revlimid
myelodysplastic syndrome
Multiple Myeloma
Celgene
Revlimid Ramp-Up, New Drug Launches Make Celgene a Buy
Motley Fool
Thu, 11/29/12 - 11:05 am
Revlimid
Celgene
Vidaza
Abraxane
apremilast
pomalidomide
Celgene's Drug Pipeline News Soothes Investor Worries
Investors.com
Thu, 09/20/12 - 11:01 am
Celgene
psoriatic arthritis
Revlimid
apremilast
Cramer: What Celgene’s Europe News Means
CNBC
Sat, 06/23/12 - 12:00 pm
Celgene
Revlimid
ONYX Pharmaceuticals
kidney cancer
liver cancer
Celgene down 13% after it pulls Revlimid filing
Marketwatch
Thu, 06/21/12 - 08:48 am
Celgene
Revlimid
Multiple Myeloma
Europe
Results from a Randomized Study of REVLIMID® (Lenalidomide) and Rituximab (R2) in Patients with Recurrent Follicular Lymphoma Presented at ASCO
Yahoo/Business Wire
Sun, 06/3/12 - 11:10 am
Revlimid
rituximab
follicular lymphoma
Cellgene
Expensive Celgene Shares A Better Bet Than Most Biotechs
Seeking Alpha
Thu, 04/5/12 - 09:10 pm
Celgene
JNJ
ONYX Pharmaceuticals
Revlimid
Pfizer
Celgene Halts Prostate-Cancer Study for Top-Selling Revlimid
Bloomberg
Wed, 11/23/11 - 09:25 am
prostate cancer
Celgene
Revlimid
Alexion, Celgene Resilient Vs. Volatile Market
Investors.com
Mon, 09/26/11 - 10:29 pm
Celgene
Alexion
Soliris
Revlimid
Celgene's Revlimid Passes EU Safety Review
TheStreet.com
Fri, 09/23/11 - 12:03 pm
Celgene
Revlimid
Europe
EU
Multiple Myeloma
Celgene Higher on Revlimid Review Chatter
TheStreet.com
Tue, 09/20/11 - 03:27 pm
Celgene
Revlimid
Revlimid side effects linked to protein in study
Reuters, UK
Tue, 08/9/11 - 10:10 am
Multiple Myeloma
Celgene
Revlimid
Phase II Data Evaluating Clinical Benefit of Revlimid Plus Rituximab for Patients with Untreated Indolent B-Cell Lymphomas Presented at International Conference on Malignant Lymphoma
Yahoo/BusinessWire
Sat, 06/18/11 - 10:00 am
Revlimid
lymphoma
rituximab
A Quick Roundup Of The New Drugs Presented At This Weekend's Huge Oncology Conference
Yahoo/Business Insider
Mon, 06/6/11 - 10:25 am
ASCO
Amgen
Aveo Pharmaceutical
Celgene
Medivation
tivozanib
abiraterone
Abraxane
AMG 479
Revlimid
Celgene Stock Falls On Worries About Secondary Cancers
Forbes
Fri, 05/6/11 - 08:37 am
Celgene
cancer
Multiple Myeloma
Revlimid
Celgene Poised to Bounce Back After Revlimid Safety Blues
Seeking Alpha
Mon, 04/25/11 - 10:25 pm
Celgene
Revlimid
drug safety
Multiple Myeloma
Two drugs, two price-setting tales
Fierce Pharma
Mon, 12/20/10 - 11:53 am
drug pricing
Celgene
Revlimid
Dainippon Sumitomo
Latuda
Celgene Raises Price Of Blood Cancer Drug Revlimid By 4.5%
WSJ Online
Fri, 12/17/10 - 11:36 am
Revlimid
Celgene
Celgene: Revlimid Cancer Risk Knocks Stock
TheStreet.com
Mon, 12/6/10 - 11:04 am
Celgene
Revlimid
Multiple Myeloma
$93,000 cancer drug: How much is a life worth?
Yahoo/AP
Sun, 09/26/10 - 12:27 pm
Provenge
Dendreon
Revlimid
Celgene

Pages